ELV Q2 2021 Earnings — Elevance Health Inc. Revenue & Financial Results | Market Cap Arena

ELVElevance Health Inc.

$64B

Q2 2021 Earnings

Healthcare Medical - Healthcare Plans

Income Statement

Revenue

$33.9B+15.7% YoY

Gross Profit

$9.1B26.8% margin

Operating Income

$2.6B7.6% margin

Net Income

$1.8B5.3% margin

EPS (Diluted)

$7.25

QoQ Revenue Growth

+4.5%

Cash Flow

Operating Cash Flow

$1.7B

Free Cash Flow

$1.4B

Stock-Based Comp.

$69M

Balance Sheet

Total Assets

$96.1B

Total Liabilities

$61.1B

Stockholders' Equity

$35.0B

Cash & Equivalents

$5.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33.9B	$29.3B	+15.7%
Gross Profit	$9.1B	$9.7B	-6.5%
Operating Income	$2.6B	$3.4B	-23.6%
Net Income	$1.8B	$2.3B	-21.2%

Revenue Segments

Government Business Segment

$20.1B52%

Commercial Specialty Business Segment

$9.6B25%

IngenioRx Segment

$6.2B16%

Other Segment

$2.5B7%